Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT01774578. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Randomized Phase IIB/III Active Control Study of Second-line Tergenpumatucel-L (Hyper-Acute(R)-Lung ) Immunotherapy Versus Docetaxel in Progressive or Relapsed Non-Small Cell Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess overall survival of anti-tumor immunization using HyperAcute®-Lung immunotherapy versus Docetaxel in patients with progressed or relapsed non-small cell lung cancer (NSCLC) that have been previously treated.
Study identification
- NCT ID
- NCT01774578
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 135 participants
Conditions and interventions
Conditions
Interventions
- Docetaxel Drug
- HyperAcute®-Lung Immunotherapy Biological
- Gemcitabine Drug
- Pemetrexed Drug
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2013 (Type not available)
- Primary completion
- May 18, 2016 (Actual)
- Completion
- Jun 18, 2016 (Actual)
- Last update posted
- May 28, 2020
2013 – 2016
United States locations
- U.S. sites
- 24
- U.S. states
- 15
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Joseph Heritage Healthcare | Santa Rosa | California | 95403 | — |
| Stamford Hospital | Stamford | Connecticut | 06902 | — |
| University of Florida | Gainesville | Florida | 32610 | — |
| Illinois Cancer Specialists | Arlington Heights | Illinois | 60005 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Deaconess Clinic | Evansville | Indiana | 47713 | — |
| Indiana University Health Goshen Center for Cancer Care | Goshen | Indiana | 46526 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| University of Kansas Cancer Center | Fairway | Kansas | 66205 | — |
| North Mississippi Hematology and Oncology Associates at BridgePoint | Tupelo | Mississippi | 38801 | — |
| Kansas City VA Medical Center | Kansas City | Missouri | 64128 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| Richmond University Medical Center | Staten Island | New York | 10310 | — |
| Wake Forest Baptist Health | Winston-Salem | North Carolina | 27103 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| University of Cincinnati | Cincinnati | Ohio | 45219 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | — |
| University of Tennessee Medical Center | Knoxville | Tennessee | 37920 | — |
| Lynchburg Hematology Oncology Clinic | Lynchburg | Virginia | 24501 | — |
| Vince Lombardi Cancer Clinic | Green Bay | Wisconsin | 54311 | — |
| University of Wisconsin | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01774578, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 28, 2020 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01774578 live on ClinicalTrials.gov.